Your screener shows you numbers. We tell you what they mean.
Everything that usually sits behind a paid plan - the query screener, 10-year ratios, indices, commodities, the results season - is free here with one account.
On top of it: an AI research desk that reads every earnings call and annual report, grades management, and gives a verdict. That part starts at ₹49.
| Feature | Typical paid platforms | GuidanceIQ |
|---|---|---|
| Query screener over every listed company | ✓ | ✓ |
| 10-year ratios and financials | ✓ | ✓ |
| Results season with filters | ✓ | ✓ |
| Index PE / PB history | ✓ | ✓ |
| Commodity cost trends | ✓ | ✓ |
| AI reads every earnings call | ✗ | ✓ |
| Management walk-the-talk scorecard | ✗ | ✓ |
| Forensic red-flag screen | ✗ | ✓ |
| A verdict with conviction, per company | ✗ | ✓ |
| Price | Paid annual plans | Free · AI deep dives from ₹49 |
Trending now
Companies investors are unlockingFeatured deep-dives
No signup needed. Full report opens on click.Accelerating multi-segment build-out compressing capital ratios; valuation registers fair
Fairly priced hospitality compounder; geopolitical headwinds and guidance volume temper conviction
Fair-valued franchise with improving returns; universal bank license the visible re-rating lever
Strong execution and sector tailwinds fully priced; working capital conversion the soft spot
Market pricing in FY30 capacity build; execution delivery the remaining variable
AI deep-dive insights
Companies with full AI research. Graded across all five lenses.
Strongest setups
12 of 130Composite ≥ 0.60 - clean across valuation, balance sheet, red flags, management, walk-the-talk.
Walking the talk
12 of 113Aggregate guidance-vs-delivered score ≥ 0.60 across every tracked promise.
High conviction picks
12 of 256Model conviction ≥ 0.60 - the thesis hangs together across every section.
Material concerns
12 of 323Forensic red flags or elevated business risk - lead with concerns, not valuation.
Across the universe · Quick insights
Built from reported financials. Every NSE-listed company is scanned and bucketed by growth, margins, cash flow, and balance sheet quality.
ROCE compounders
12 of 636Steady ROCE ≥ 18% over the last three years with rising sales.
Net cash quality
12 of 227Net-cash balance sheet with healthy cash conversion.
Operating leverage primed
12 of 858Recent margin expansion with rising capacity utilisation.
Steady payers
12 of 179Consistent dividend record with healthy payout ratio.
Caution - levering up
12 of 756Debt growing materially faster than equity or earnings.